About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Charles River Introduces Global Biotech Incubator Program

Program offers biotechnology developers access to extensive scientific expertise and a wide ecosystem of discovery, development and manufacturing capabilities

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of the Charles River Incubator Program (CIP), specializing in supporting early-stage biotechnology companies in the discovery, development and phase-appropriate manufacturing of advanced therapies.

“The Charles River Incubator Program launch, through our Global Innovation Center of Excellence, demonstrates a continued commitment to the global biotechnology industry by offering knowledge, connectivity, and priority access to the Charles River portfolio,” said Kerstin Dolph, Corporate Senior Vice President, Global Manufacturing, Charles River.

Building on the success of the Company’s established global Cell and Gene Therapy (CGT) Accelerator Program (CAP), the CIP focuses on nurturing innovative start-up and early-stage biotechnology companies. The objective of the CIP is to form a strong foundation for commercial viability as its participants gain momentum with the goal of imparting cost-effective, consultative regulatory and quality expertise, personnel training initiatives, and enabling access to laboratory space and equipment. Developers are invited to apply to be part of the next cohort today:

  • CIP – Incubates biotechnology developers in the discovery phase, 24+ months from Investigational New Drug (IND) or Clinical Trial Application (CTA) submission.
  • CAP – Accelerates advanced therapy developers 18-24 months from IND or CTA submission.

Leveraging a Concept to Cure Portfolio

The CIP and CAP are reinforced by the Company’s Global Innovation Center of Excellence (CoE), strategically positioned and fully integrated at the heart of Charles River’s extensive virtual and physical network. The Global Innovation CoE amalgamates a cross-functional team of scientific, regulatory and manufacturing experts in:

  • Drug Discovery
  • Safety Assessment
  • Research Models
  • Clinical to Commercial Contract Development and Manufacturing
  • Microbial Solutions

Based out of the Company’s contract development and manufacturing organization (CDMO) CoE located in the Alderley Park campus, the UK’s largest, single-site life science ecosystem, the Global Innovation CoE is geared to foster and accelerate life sciences innovation, with enhanced access to life sciences and biotechnology experts.

In alignment with the Company’s strategic areas of interest and commitment to driving innovation, the applicant selection process remains at the discretion of Charles River and the next cohort shortlist will be identified in conjunction with the upcoming Cell and Gene Therapy Summit, March 4, 2025, in San Francisco, CA.

Our Experts: An Extension of Your Team

Bolstering its concept to cure capabilities, Charles River is proud to showcase a world-class team of scientific experts across the drug development continuum, providing broad experience and consultative advice.

With distinguished operational, quality, and regulatory experts including previous FDA, EMA, and MHRA advisors, the integrated network of Charles River professionals has supported thousands of IND and CTA submissions, reducing overall risk and setting programs up for success.

Meet with a Charles River expert at Advanced Therapies Week, January 20-23, 2025, in Dallas, TX to discuss the Global Innovation CoE, CIP, and how our cross-functional team and fit-for purpose facilities can support your program from concept to cure. Schedule a meeting: https://bit.ly/3ZjKKla

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

Contacts

Charles River Investor:

Todd Spencer

Corporate Vice President,

Investor Relations

781.222.6455

todd.spencer@crl.com

Charles River Media:

Amy Cianciaruso

Corporate Vice President,

Chief Communications Officer

781.222.6168

amy.cianciaruso@crl.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.